Treatment of MCF-7 and MDA-MB-231 human breast cancer cell lines with erythropoietin, doxorubicin and their combination
The cancer chemotherapies are formulated to target the rapidly proliferating cancer cells more efficiently than those normal cells of low proliferating rate. In cancer therapies erythropoietin (EPO) is often used in combination with chemotherapeutic drugs to treat the cancer-associated anemia. In th...
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Thesis |
| Lingua: | English |
| Pubblicazione: |
2015
|
| Accesso online: | http://psasir.upm.edu.my/id/eprint/70913/1/FPV%202015%203%20-%20IR.pdf |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|